An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Nanobodies that neutralize
Monoclonal antibodies that bind to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show therapeutic promise but must be produced in mammalian cells and need to be delivered intravenously. By contrast, single-domain antibodies called nanobodies can be produced in bacteria or yeast, and their stability may enable aerosol delivery. Two papers now report nanobodies that bind tightly to spike and efficiently neutralize SARS-CoV-2 in cells. Schoof et al. screened a yeast surface display of synthetic nanobodies and Xiang et al. screened anti-spike nanobodies produced by a llama. Both groups identified highly potent nanobodies that lock the spike protein in an inactive conformation. Multivalent constructs of selected nanobodies achieved even more potent neutralization.
Science
, this issue p.
Top-30
Citations by journals
2
4
6
8
10
12
|
|
Frontiers in Immunology
12 publications, 3.65%
|
|
International Journal of Molecular Sciences
10 publications, 3.04%
|
|
Nature Communications
8 publications, 2.43%
|
|
Proceedings of the National Academy of Sciences of the United States of America
7 publications, 2.13%
|
|
Viruses
5 publications, 1.52%
|
|
iScience
5 publications, 1.52%
|
|
Journal of Biological Chemistry
5 publications, 1.52%
|
|
Journal of Virology
5 publications, 1.52%
|
|
International Journal of Biological Macromolecules
4 publications, 1.22%
|
|
Scientific Reports
3 publications, 0.91%
|
|
Journal of Nanobiotechnology
3 publications, 0.91%
|
|
Cell Reports
3 publications, 0.91%
|
|
Acta Pharmaceutica Sinica B
3 publications, 0.91%
|
|
Journal of Chemical Information and Modeling
3 publications, 0.91%
|
|
Biochemistry
3 publications, 0.91%
|
|
mAbs
3 publications, 0.91%
|
|
Science
3 publications, 0.91%
|
|
Antiviral Research
3 publications, 0.91%
|
|
International Journal of Nanomedicine
2 publications, 0.61%
|
|
Vaccines
2 publications, 0.61%
|
|
Antibodies
2 publications, 0.61%
|
|
Molecules
2 publications, 0.61%
|
|
Communications Biology
2 publications, 0.61%
|
|
Cell
2 publications, 0.61%
|
|
Current Opinion in Structural Biology
2 publications, 0.61%
|
|
Chem
2 publications, 0.61%
|
|
Biochemical and Biophysical Research Communications
2 publications, 0.61%
|
|
Biomedicine and Pharmacotherapy
2 publications, 0.61%
|
|
Biochimica et Biophysica Acta - General Subjects
2 publications, 0.61%
|
|
2
4
6
8
10
12
|
Citations by publishers
10
20
30
40
50
60
70
|
|
Cold Spring Harbor Laboratory
68 publications, 20.67%
|
|
Elsevier
58 publications, 17.63%
|
|
Springer Nature
50 publications, 15.2%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
30 publications, 9.12%
|
|
American Chemical Society (ACS)
23 publications, 6.99%
|
|
Wiley
16 publications, 4.86%
|
|
Frontiers Media S.A.
15 publications, 4.56%
|
|
American Society for Microbiology
10 publications, 3.04%
|
|
Oxford University Press
7 publications, 2.13%
|
|
American Association for the Advancement of Science (AAAS)
7 publications, 2.13%
|
|
Proceedings of the National Academy of Sciences (PNAS)
7 publications, 2.13%
|
|
Royal Society of Chemistry (RSC)
6 publications, 1.82%
|
|
Taylor & Francis
6 publications, 1.82%
|
|
American Society for Biochemistry and Molecular Biology
5 publications, 1.52%
|
|
Dove Medical Press
2 publications, 0.61%
|
|
Public Library of Science (PLoS)
2 publications, 0.61%
|
|
EMBO press
2 publications, 0.61%
|
|
eLife Sciences Publications
2 publications, 0.61%
|
|
The Chemical Society of Japan
1 publication, 0.3%
|
|
Microbiology Society
1 publication, 0.3%
|
|
Cambridge University Press
1 publication, 0.3%
|
|
Rockefeller University Press
1 publication, 0.3%
|
|
Hindawi Limited
1 publication, 0.3%
|
|
KeAi Communications Co.
1 publication, 0.3%
|
|
The Company of Biologists
1 publication, 0.3%
|
|
The Royal Society
1 publication, 0.3%
|
|
Spandidos Publications
1 publication, 0.3%
|
|
Annual Reviews
1 publication, 0.3%
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.3%
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.